Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
PTEN Phosphohydrolase | 14 | 2020 | 1117 | 0.800 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2015 | 1331 | 0.410 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2018 | 2945 | 0.350 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2016 | 2056 | 0.340 |
Why?
|
Neoplasm Proteins | 4 | 2021 | 3594 | 0.320 |
Why?
|
Prostatic Neoplasms | 11 | 2020 | 11092 | 0.310 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 2021 | 249 | 0.300 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2021 | 5334 | 0.300 |
Why?
|
Tumor Suppressor Proteins | 4 | 2019 | 2793 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2024 | 2454 | 0.280 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2024 | 3605 | 0.280 |
Why?
|
Disease Models, Animal | 11 | 2020 | 18314 | 0.280 |
Why?
|
Mice | 41 | 2024 | 81821 | 0.260 |
Why?
|
Anilides | 2 | 2020 | 413 | 0.260 |
Why?
|
Antineoplastic Agents | 7 | 2024 | 13634 | 0.250 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2005 | 88 | 0.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 6 | 2024 | 5388 | 0.250 |
Why?
|
Cytochromes c | 1 | 2005 | 173 | 0.240 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2018 | 101 | 0.240 |
Why?
|
Cell Line, Tumor | 21 | 2024 | 17070 | 0.230 |
Why?
|
Pericytes | 2 | 2018 | 299 | 0.220 |
Why?
|
RNA, Ribosomal | 2 | 2019 | 227 | 0.220 |
Why?
|
Animals | 47 | 2024 | 168775 | 0.210 |
Why?
|
Indoles | 3 | 2019 | 1832 | 0.210 |
Why?
|
Pantothenic Acid | 1 | 2022 | 17 | 0.200 |
Why?
|
Nuclear Proteins | 6 | 2019 | 5791 | 0.200 |
Why?
|
Coenzyme A | 1 | 2022 | 39 | 0.200 |
Why?
|
Neoplasm Metastasis | 4 | 2018 | 4886 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 1406 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2021 | 8613 | 0.190 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2022 | 125 | 0.190 |
Why?
|
Computational Biology | 1 | 2013 | 3563 | 0.190 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8037 | 0.180 |
Why?
|
Caspases | 1 | 2004 | 881 | 0.180 |
Why?
|
Nipples | 1 | 2023 | 222 | 0.180 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 1897 | 0.180 |
Why?
|
Androgen Receptor Antagonists | 1 | 2021 | 123 | 0.170 |
Why?
|
Sesquiterpenes | 1 | 2021 | 175 | 0.170 |
Why?
|
Lipogenesis | 2 | 2020 | 217 | 0.170 |
Why?
|
Glucose Transporter Type 3 | 1 | 2019 | 16 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2021 | 2878 | 0.160 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13482 | 0.160 |
Why?
|
Trans-Activators | 1 | 2009 | 2849 | 0.160 |
Why?
|
Dyskeratosis Congenita | 1 | 2019 | 70 | 0.160 |
Why?
|
Quinolines | 1 | 2024 | 769 | 0.160 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2021 | 496 | 0.160 |
Why?
|
Mutation | 10 | 2021 | 30208 | 0.160 |
Why?
|
Thyroid Neoplasms | 3 | 2018 | 2355 | 0.150 |
Why?
|
Cytoplasm | 3 | 2013 | 1498 | 0.150 |
Why?
|
Sterol Regulatory Element Binding Proteins | 1 | 2018 | 25 | 0.150 |
Why?
|
Databases, Factual | 1 | 2013 | 8062 | 0.150 |
Why?
|
Organoids | 2 | 2021 | 741 | 0.140 |
Why?
|
Caveolin 1 | 1 | 2019 | 255 | 0.140 |
Why?
|
Anticarcinogenic Agents | 1 | 2019 | 250 | 0.140 |
Why?
|
Protein Phosphatase 1 | 1 | 2018 | 135 | 0.140 |
Why?
|
Lipoylation | 1 | 2018 | 87 | 0.140 |
Why?
|
Cell Proliferation | 10 | 2024 | 10431 | 0.140 |
Why?
|
Pyridines | 2 | 2020 | 2889 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2019 | 392 | 0.140 |
Why?
|
Growth and Development | 1 | 2016 | 46 | 0.140 |
Why?
|
Molecular Targeted Therapy | 4 | 2021 | 2825 | 0.140 |
Why?
|
Signal Transduction | 14 | 2022 | 23600 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2019 | 3636 | 0.130 |
Why?
|
Apoptosis | 5 | 2021 | 9507 | 0.130 |
Why?
|
Cell Cycle Proteins | 2 | 2024 | 3436 | 0.130 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2018 | 2054 | 0.130 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2016 | 42 | 0.130 |
Why?
|
Neoplasms | 5 | 2019 | 22336 | 0.130 |
Why?
|
DNA, Intergenic | 1 | 2016 | 108 | 0.130 |
Why?
|
Mice, Transgenic | 10 | 2021 | 9536 | 0.130 |
Why?
|
Tretinoin | 1 | 2019 | 524 | 0.130 |
Why?
|
Proteomics | 2 | 2024 | 3907 | 0.130 |
Why?
|
RNA-Binding Proteins | 2 | 2016 | 1883 | 0.130 |
Why?
|
Benzimidazoles | 1 | 2021 | 862 | 0.130 |
Why?
|
Fertility | 1 | 2020 | 770 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 323 | 0.130 |
Why?
|
HMGB1 Protein | 1 | 2017 | 139 | 0.120 |
Why?
|
Cholesterol | 1 | 2024 | 2901 | 0.120 |
Why?
|
Genetic Pleiotropy | 1 | 2016 | 182 | 0.120 |
Why?
|
Pyrazines | 1 | 2021 | 1204 | 0.120 |
Why?
|
RNA, Messenger | 5 | 2019 | 12772 | 0.120 |
Why?
|
Animal Husbandry | 1 | 2015 | 64 | 0.120 |
Why?
|
Chemokine CXCL12 | 1 | 2017 | 455 | 0.120 |
Why?
|
Transcription Factors | 5 | 2021 | 12128 | 0.120 |
Why?
|
Hematopoiesis | 1 | 2004 | 2060 | 0.120 |
Why?
|
Receptors, Androgen | 1 | 2021 | 1088 | 0.120 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2018 | 637 | 0.120 |
Why?
|
Mice, SCID | 4 | 2021 | 2625 | 0.120 |
Why?
|
Elafin | 1 | 2014 | 29 | 0.120 |
Why?
|
Phthalazines | 1 | 2017 | 397 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2018 | 2838 | 0.110 |
Why?
|
Multiprotein Complexes | 3 | 2016 | 1107 | 0.110 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 71 | 0.110 |
Why?
|
Hematopoietic Stem Cells | 2 | 2019 | 3405 | 0.110 |
Why?
|
Epigenomics | 1 | 2019 | 959 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 997 | 0.110 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2022 | 433 | 0.110 |
Why?
|
RNA | 2 | 2021 | 2715 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5695 | 0.110 |
Why?
|
Public Sector | 1 | 2015 | 265 | 0.110 |
Why?
|
Mice, Knockout | 8 | 2021 | 14455 | 0.110 |
Why?
|
Genes, Neoplasm | 1 | 2015 | 369 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1621 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2021 | 5454 | 0.110 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 415 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1765 | 0.100 |
Why?
|
Drug Repositioning | 1 | 2015 | 245 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 955 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2021 | 1762 | 0.100 |
Why?
|
NF-kappa B | 1 | 2021 | 2495 | 0.100 |
Why?
|
Therapies, Investigational | 1 | 2013 | 110 | 0.100 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2014 | 428 | 0.100 |
Why?
|
Gallbladder Neoplasms | 1 | 2014 | 190 | 0.100 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2012 | 83 | 0.100 |
Why?
|
Muscles | 1 | 2016 | 1576 | 0.100 |
Why?
|
Enzyme Activation | 1 | 2018 | 3584 | 0.100 |
Why?
|
Private Sector | 1 | 2015 | 396 | 0.100 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2015 | 323 | 0.090 |
Why?
|
Humans | 50 | 2024 | 766000 | 0.090 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 9600 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2021 | 3684 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1885 | 0.090 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1490 | 0.090 |
Why?
|
Neutrophils | 2 | 2020 | 3770 | 0.090 |
Why?
|
Histones | 1 | 2021 | 2591 | 0.090 |
Why?
|
Naphthyridines | 1 | 2012 | 184 | 0.090 |
Why?
|
Ribosomes | 1 | 2013 | 495 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 496 | 0.080 |
Why?
|
Myeloid Cells | 2 | 2018 | 838 | 0.080 |
Why?
|
Lysosomes | 3 | 2021 | 932 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3249 | 0.080 |
Why?
|
Breast Neoplasms | 4 | 2023 | 21072 | 0.080 |
Why?
|
Oncogene Proteins | 2 | 2016 | 711 | 0.080 |
Why?
|
Chromatin | 1 | 2021 | 2980 | 0.080 |
Why?
|
HEK293 Cells | 4 | 2019 | 4262 | 0.080 |
Why?
|
Nanoparticles | 1 | 2020 | 1965 | 0.080 |
Why?
|
Interprofessional Relations | 1 | 2015 | 998 | 0.080 |
Why?
|
Drug Synergism | 2 | 2024 | 1753 | 0.080 |
Why?
|
Oncogenes | 2 | 2021 | 1231 | 0.080 |
Why?
|
Purines | 1 | 2012 | 616 | 0.080 |
Why?
|
Sarcoma | 1 | 2019 | 1801 | 0.070 |
Why?
|
Immunotherapy | 2 | 2021 | 4746 | 0.070 |
Why?
|
Drug Approval | 1 | 2015 | 820 | 0.070 |
Why?
|
Medical Informatics | 1 | 2015 | 743 | 0.070 |
Why?
|
Regeneration | 1 | 2016 | 1516 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11906 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7192 | 0.070 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3942 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1065 | 0.070 |
Why?
|
Piperazines | 1 | 2017 | 2547 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1167 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1242 | 0.070 |
Why?
|
Mass Spectrometry | 3 | 2022 | 2197 | 0.060 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2009 | 657 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4565 | 0.060 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2005 | 70 | 0.060 |
Why?
|
Androgens | 1 | 2013 | 1278 | 0.060 |
Why?
|
Open Reading Frames | 2 | 2020 | 818 | 0.060 |
Why?
|
Models, Biological | 6 | 2018 | 9446 | 0.060 |
Why?
|
Gene Expression Profiling | 5 | 2021 | 9524 | 0.060 |
Why?
|
Genome, Human | 1 | 2018 | 4442 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2927 | 0.060 |
Why?
|
Two-Hybrid System Techniques | 1 | 2005 | 463 | 0.060 |
Why?
|
Mice, Nude | 2 | 2021 | 3610 | 0.060 |
Why?
|
Peptides | 1 | 2016 | 4338 | 0.060 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2005 | 195 | 0.060 |
Why?
|
bcl-2-Associated X Protein | 1 | 2005 | 282 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1980 | 0.060 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2024 | 58 | 0.060 |
Why?
|
Androgen Antagonists | 1 | 2013 | 1411 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2046 | 0.060 |
Why?
|
Gene Knockout Techniques | 2 | 2019 | 800 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 22334 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 702 | 0.060 |
Why?
|
Ubiquitination | 2 | 2019 | 1000 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 3048 | 0.050 |
Why?
|
RNA, Neoplasm | 1 | 2006 | 744 | 0.050 |
Why?
|
Proteome | 1 | 2013 | 1895 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1836 | 0.050 |
Why?
|
Male | 21 | 2021 | 363855 | 0.050 |
Why?
|
Keratin-7 | 1 | 2023 | 55 | 0.050 |
Why?
|
Mitosis | 2 | 2024 | 1175 | 0.050 |
Why?
|
Proteins | 3 | 2018 | 5994 | 0.050 |
Why?
|
Endosomes | 2 | 2016 | 521 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2004 | 738 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1677 | 0.050 |
Why?
|
Acetyl Coenzyme A | 1 | 2022 | 74 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6101 | 0.050 |
Why?
|
Protein Stability | 1 | 2024 | 576 | 0.050 |
Why?
|
Phosphorylation | 2 | 2024 | 8290 | 0.050 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
Telomerase | 1 | 2006 | 749 | 0.050 |
Why?
|
Gene Amplification | 2 | 2018 | 1088 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2009 | 1996 | 0.050 |
Why?
|
Blotting, Western | 2 | 2009 | 5019 | 0.050 |
Why?
|
Gene Silencing | 3 | 2018 | 1505 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3529 | 0.050 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1749 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 3423 | 0.040 |
Why?
|
Cell Cycle | 2 | 2024 | 2921 | 0.040 |
Why?
|
Gene Expression | 1 | 2013 | 7581 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 628 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 361 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1150 | 0.040 |
Why?
|
RNA, Small Nucleolar | 1 | 2019 | 27 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1142 | 0.040 |
Why?
|
HeLa Cells | 1 | 2005 | 3070 | 0.040 |
Why?
|
Spermatogenesis | 1 | 2020 | 259 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2021 | 924 | 0.040 |
Why?
|
Leukemia | 1 | 2007 | 1521 | 0.040 |
Why?
|
U937 Cells | 1 | 2019 | 259 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3750 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2019 | 320 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11858 | 0.040 |
Why?
|
COS Cells | 1 | 2020 | 1135 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 898 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2018 | 364 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5695 | 0.040 |
Why?
|
RNA Interference | 1 | 2005 | 2825 | 0.030 |
Why?
|
Endocytosis | 1 | 2021 | 952 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2021 | 886 | 0.030 |
Why?
|
Cell Communication | 1 | 2024 | 1660 | 0.030 |
Why?
|
Methylation | 1 | 2019 | 1074 | 0.030 |
Why?
|
K562 Cells | 1 | 2018 | 644 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2021 | 1715 | 0.030 |
Why?
|
RNA Splicing | 1 | 2021 | 902 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1130 | 0.030 |
Why?
|
Cytarabine | 1 | 2018 | 696 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2022 | 2001 | 0.030 |
Why?
|
Benzylamines | 1 | 2017 | 251 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2008 | 1926 | 0.030 |
Why?
|
Heterocyclic Compounds | 1 | 2017 | 245 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 4910 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 938 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1889 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3692 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2017 | 475 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2005 | 4342 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2018 | 735 | 0.030 |
Why?
|
Microtubules | 1 | 2020 | 1062 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2019 | 959 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1102 | 0.030 |
Why?
|
Polysaccharides | 1 | 2020 | 1017 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1227 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2018 | 682 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1895 | 0.030 |
Why?
|
Heterozygote | 2 | 2011 | 2796 | 0.030 |
Why?
|
Protein Binding | 1 | 2005 | 9302 | 0.030 |
Why?
|
Exons | 1 | 2019 | 2392 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 380 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 799 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4016 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1674 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2016 | 555 | 0.030 |
Why?
|
Valine | 1 | 2014 | 410 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2016 | 839 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3604 | 0.030 |
Why?
|
Gene Duplication | 1 | 2013 | 316 | 0.030 |
Why?
|
Nanostructures | 1 | 2017 | 549 | 0.020 |
Why?
|
Cell Membrane | 1 | 2021 | 3635 | 0.020 |
Why?
|
Testosterone | 1 | 2023 | 2495 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 1966 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1105 | 0.020 |
Why?
|
Genotype | 2 | 2018 | 13029 | 0.020 |
Why?
|
Phenylthiohydantoin | 1 | 2013 | 206 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5739 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2013 | 663 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3586 | 0.020 |
Why?
|
Orchiectomy | 1 | 2013 | 465 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2898 | 0.020 |
Why?
|
Amino Acids | 1 | 2016 | 1711 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2017 | 1155 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6506 | 0.020 |
Why?
|
Cell Line | 1 | 2004 | 15545 | 0.020 |
Why?
|
Genes, myc | 1 | 2011 | 391 | 0.020 |
Why?
|
Fatty Acids | 1 | 2018 | 1806 | 0.020 |
Why?
|
Alleles | 2 | 2013 | 6892 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2016 | 1017 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2535 | 0.020 |
Why?
|
Female | 8 | 2024 | 396158 | 0.020 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2010 | 122 | 0.020 |
Why?
|
Pheochromocytoma | 1 | 2011 | 326 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1603 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4133 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2009 | 439 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5194 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10089 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4520 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 1181 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1663 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2897 | 0.020 |
Why?
|
Mammals | 1 | 2013 | 1125 | 0.020 |
Why?
|
Nitriles | 1 | 2013 | 981 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2013 | 18964 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 858 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4335 | 0.020 |
Why?
|
Benzamides | 1 | 2013 | 1376 | 0.020 |
Why?
|
Adenovirus E1A Proteins | 1 | 2007 | 81 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 65199 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2653 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2010 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2010 | 1058 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1211 | 0.020 |
Why?
|
Homozygote | 1 | 2010 | 1775 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2017 | 3077 | 0.010 |
Why?
|
Zebrafish | 1 | 2016 | 3035 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4783 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 1674 | 0.010 |
Why?
|
Cell Separation | 1 | 2009 | 1718 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6361 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2667 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2011 | 1351 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5775 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2010 | 2091 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12405 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7599 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13400 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 2390 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17597 | 0.010 |
Why?
|
Lung | 1 | 2019 | 10060 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10260 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3448 | 0.010 |
Why?
|
DNA Damage | 1 | 2010 | 2464 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29904 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 943 | 0.010 |
Why?
|
Fibroblasts | 1 | 2010 | 4161 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5879 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5784 | 0.010 |
Why?
|
Myelodysplastic Syndromes | 1 | 2008 | 1404 | 0.010 |
Why?
|
Middle Aged | 2 | 2023 | 223025 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9378 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11642 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59493 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2006 | 2532 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11035 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 18076 | 0.000 |
Why?
|
Aged | 1 | 2020 | 171161 | 0.000 |
Why?
|
Adult | 1 | 2020 | 223106 | 0.000 |
Why?
|